Search results
Results from the Health.Zone Content Network
History Early years. The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales, and in 1984, the company adopted the name Danaher and ...
List of largest biomedical companies by market capitalization. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization. It does not include biotechnology companies that ...
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.He was convicted of financial crimes for which he served over 6 years in federal prison and was fined over 70 million dollars.
Dimethylglycine is an essential amino acid, which means that the body cannot make this chemical on its own. It must be consumed in the diet. It is found in grains and meats and can also be taken ...
When taken orally in high doses, inhaled, or used topically, DMAE has been associated with several potential risks, according to the National Institutes of Health (NIH). These include: skin ...
Overall rating 4.7. Effectiveness. Ease of Use. Satisfaction. Little info is available on this supplement of the future that boasts an array of health benefits. I initially starting taking DMG for athletic performance after finding it at the buttom of the shelf at a nutrition store.
Syneos Health. Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also ...
Currently, J&J's performance is mostly driven by pharmaceutical drugs, which accounted for $13.6 billion of the $21.4 billion reported in the first quarter. The company spent about $3 billion on ...